NCT06582004View on ClinicalTrials.gov

Comparisons of the Effects and Clinical Outcomes of CH2 Vaginal Gel Versus Placebo on CIN1

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

November 30, 2025

Conditions
Cervical Intraepithelial NeoplasiaHuman Papillomavirus
Interventions
DIETARY_SUPPLEMENT

CH2 vaginal gel

The usage frequency is 2 units per week, with a 3-day interval between each unit, for a total duration of 24 weeks

DIETARY_SUPPLEMENT

Placebo hyaluronic acid gel

The usage frequency is 2 units per week, with a 3-day interval between each unit, for a total duration of 24 weeks

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT06582004 - Comparisons of the Effects and Clinical Outcomes of CH2 Vaginal Gel Versus Placebo on CIN1 | Biotech Hunter | Biotech Hunter